Close
Enter your
text here

Sarcoma

From Biology to Bedside: How the Center for Childhood Cancer Research Is Shaping What Comes Next
 From Biology to Bedside: How the Center for Childhood Cancer Research Is Shaping What Comes Next 1024 627 Madison Storm
By: Madison Storm
Portrait of Alexander Bishop, DPhil, standing in a hospital lobby and smiling, wearing a navy blazer and light blue shirt.

An interview with Alexander Bishop, DPhil, director of the Center for Childhood Cancer Research, principal investigator and Richard J. Solove Endowed Chair in Cancer Clinical Developmental Therapeutics at Nationwide Children’s Hospital. At Nationwide Children’s Hospital, the mission of the Center for Childhood Cancer Research (CCCR) is to expand the understanding of childhood cancer pathogenesis and…

Filling a Critical Gap in Relapsed Sarcoma Treatment
 Filling a Critical Gap in Relapsed Sarcoma Treatment 1024 683 Pam Georgiana
By: Pam Georgiana
Blood Sample in test tube

A first-in-sarcoma trial at Nationwide Children’s Hospital tests universal-donor NK cells with chemotherapy to address poor survival rates.   The five-year overall survival rate for children and young adults with relapsed bone or soft tissue sarcomas is between 17 and 26%. For Bhuvana A. Setty, MD, pediatric hematologist and oncologist at Nationwide Children’s Hospital, that reality is not acceptable. …

Transforming the Approach to Cancer Epigenomic Studies
 Transforming the Approach to Cancer Epigenomic Studies 1024 764 Abbie Miller
By: Abbie Miller

Two new publications from the Center for Childhood Cancer Research at Nationwide Children’s offer a new platform technology and proof of concept that illuminates the role of a known gene fusion driving rhabdomyosarcoma.  Synergy is an important part of scientific endeavors, and people, teams and organizations who can harness the energy of ideas and passion…